RounZ

Foundation Memetic Agents Log

rating: 0+x
psiagent.pngWARNING!psiagent.png
THIS LOG IS TO BE ACCESSED BY MEMBERS OF MTF ETA-10 'SEE NO EVIL' ONLY AND REQUIRES LEVEL 4 AUTHORIZATION FROM THE MEMETICS AND INFOHAZARDS DIVISION. THE MEMETIC AGENTS DISPLAYED ARE ACTIVE AND REQUIRE THE PROSCRIBED SENSORY SCRAMBLING EQUIPMENT FOR VIEWING. CONTINUING WITHOUT THE PROPER CLEARANCE OR SAFETY MEASURES WILL RESULT IN SEIZURES, COMA OR DEATH.

Template for Memetic Agents Entries

Name:
Class: Amnestic, Information Security, Defensive Countermemetics, Incapacitation, Termination
Handling and Usage Instructions:
Clearance level required, appropriate safeguards for installation and activation, etc.
Effects: Target population, effects-immediate and long term
Development: Relevant history and development, results of laboratory and field tests
Addenda: additional notes

Please contact Memetic Handling Safety Officer Dr. Rounds about posting additional entries.


Name: LISE

Class: Information Security

Handling and Usage Instructions: The LISE agent is embedded in all documentation which refers to the Foundation. Foundation staff are inoculated against LISE as part of the orientation process.

Effects: Individuals exposed to the LISE agent become convinced that the information containing LISE are untrue. Subjects create explanations as to why the materials are untrue, and vary between subjects. Common explanations include reports made in error, the documentation is a hoax, front for a conspiracy, or intentional work of fiction. Affected individuals respond with irritation and dismiss further evidence the Foundation is real, and will refuse to engage in further discussion of the topic.

Development: The LISE agent was developed as an alternative to routine mass amnestic use following information security breaches. The LISE agent is derived from QUESTION and EVERYTHING.

Addendum: While Foundation personnel are inoculated against this agent, the counter-memetics are not effective for all personnel. The current loss rate of Foundation personnel exposed to the LISE agent is .09%. The severe cognitive dissonance required to reconcile the belief that all Foundation documents and materials are untrue results in paranoia and dissociative symptoms often culminating in psychotic breaks. In such cases class F Amnestics, which are effective in eliminating the symptoms for 38.2% of affected Foundation employees, are approved for use followed by re-integration into the general population.



Name: PRIME

Class: Defensive Counter-memetics Foundation Loyalty Conditioning

Handling and Usage Instructions: All Foundation staff working in facilities containing cognitohazardous or memetic anomalies are to receive the PRIME counter-memetic array.

Effects: The PRIME array of countermemetics protect Foundation staff from many known compulsive memetics and cognitohazards. It delays the effects of several more powerful agents, and has been shown to benefit Foundation personnel in the field when encountering memetic and some mind-affecting anomalies. PRIME ensures staff productivity, retention, psychiatric stability and unquestioning loyalty to the Foundation.
Development: The PRIME array of countermemetics has been continually under development since the inception of the Memetics and Infohazards Division. Counter-memetic agents have been developed through reverse engineering of memetic anomalies in the Foundation's possession. The most recent array has decreased loss of Foundation staff to memetic anomalies by 23% compared with civilian populations. PRIME has decreased staff turnover/nervous collapse by 31% and improved productivity by 13%.


Name: MAIS

Class: Incapacitation

Handling and Usage Instructions: The MAIS agent is to be used in high security areas where capture of unauthorized individuals is prioritized over termination.

Effects: Individuals affected by the MAIS agent become catatonic. For 97.2% of individuals exposed the catatonia may only be reversed with amnestics, although there appears to be a moderate decrease in performance IQ after exposure. However, 2.8% of exposed individuals ceased displaying catatonic symptoms without aid. Follow-up studies determined these individuals possessed high levels of natural resistance to memetic agents, as well as a natural facility in research of memetic anomalies. The duration of the catatonic stupor among these individuals varies with the longest duration at eight weeks, and the record for fastest symptom remission twenty-three minutes held by current Memetics and Infohazards Division. director Dr. Janice Millgrahm.

Development: The MAIS agent was one of the first memetic agents to be successfully created wholly through the efforts of Foundation memeticists. While due to the insufficient security protocols used at that time, several of the developers were exposed to the agent, all members of the research team recovered within a week.

Addendum: The request to use the MAIS for screening and training by the Memetics and Infohazards Division. is rejectedunder review. MAIS is a standard part of memeticist training.


Name: AZFXE8

Class: Incapacitation/Termination

Handling and Usage Instructions: Individuals with predisposition to panic attacks, asthma, and seizures are particularly susceptible to the effects of this agent, and staff with any of these conditions are prohibited from accessing this defense regardless of clearance levels or protective measures used.

Effects: The AZFXE8 agent has been effective at incapacitating 89.6% of subjects exposed, with the remaining 5.4% expiring from asphyxiation. Prolonged exposure leads to a 37.5% fatality rate, although the asphyxiation may be delayed with an artificial respirator.

Development: AZFXE8 has been in continual development over the past two decades to refine its effects, and testing with D-Class in lieu of or as a means of termination has been authorized.


Name: BRAKE

Class: Incapacitation/Termination

Handling and Usage Instructions: Foundation staff with any implanted devices, including Foundation issue technology, may not access this memetic agent.

Effects: Perception of the BRAKE agent interferes with the successful communication between a human body and technology based implants. This results in partial to complete rejection of implants. Field use has resulted in injuries, disfigurement and death depending on the nature of the implant(s).

Development: The BRAKE agent was initially developed to combat attempted containment breach attempts by Group of Interest-004, "The Church of the Broken God". The agent has been found to be effective for most technological implants.

The initial high success rate of the agent lead to testing as a possible treatment for SCP-217 infection. Initial brief exposure to the agent inhibited the progress of infection, and halted it after exposure lasting several hours. Cessation of the course of infection appeared to occur for several days up to a week in test trials. However these periods were followed by a resurgence of the viral infection leading to a complete conversion over the course of 48 hours in every test conducted. In addition two Foundation laboratory technicians were infected with the more virulent strain despite no detectable breach of quarantine. All further research of memetic agents has since been restricted to their original purpose only by order of Director Millgrahm.

Addendum: The "Church of Maxwellism" (GOI-004C) members appear to have developed an immunity to the BRAKE agent. Updated versions of the agent are continuously being developed in order to target Maxwellists. The latest version is 3.2.2.BRAKE unfortunately renders subdermal and subcortical Foundation implants inoperative. Replacements must be provided to affected Foundation personell.


Name: CTE Memetic Agent for Reality Benders

Class: Termination

Handling and Usage Instructions: Staff members with anomalous properties may not access this agent or areas where this agent is utilized.

Effects: The CTE memetic agent is presumed to be effective against reality benders and anomalous beings with similar properties. Due to the lack of data on the agent's use, the effectiveness and limitations of this defense are unknown.

When viewed by individuals or entities without reality bending properties CTE agents produce a slight increase in blood pressure, which is extinguished with continued exposure. The minimal risk for non-reality bending individuals makes the use of CTE agents extremely practical. In instances in which the cost of Scranton-Reality Anchors is prohibitive, use of CTE should be standard procedure.

Development: Although records are incomplete the CTE Memetic Agent was developed in 1984 by Doctors Millgrahm and NoTelling. It is assumed that due to the urgent need for defensive measures effective against reality bending entities they were put into widespread use immediately. While continued development and testing were expected to be conducted with field use, there are no recorded successful or unsuccessful utilizations of the CTE agent between their adoption in 1984 and 1999. Following a security audit in which they were found to be superfluous due to their apparent lack of utilization they were removed from widespread use in 1999.

In 2006 a review of Foundation policies included an analysis of reality bender incursions and containment breaches over the past 50 years. While records were at best incomplete due to the nature of the subject matter there were highly significant decreases in security incidents, controlling for the increasing numbers of SCPs over time, in the 15 year span CTE measures were in use. In the resulting report the theory was put forth that the effect resulting from CTE's use was retroactive. The potential risk of unfavorable temporal shifts as a result of the agent's use are considered as acceptable compared to the danger posed by uncontained reality bending entities.

Subsequently CTE defenses were reinstated in high security areas, after which security incident rates returned to previous levels.

Addendum: At present there are no documented incidents in which CTE agent has been utilized, however this is an expected consequence of the presumed nature of the agent's mechanism. The lack of records may be an indication of success or an artifact of successful circumventing of the CTE agents. WARNING: Foundation staff with anomalous properties are not to access CTE defenses.


Name: Kill Word

Class: Termination

Handling and Usage Instructions: Members of MTF Eta-10's Kikazaru Squad are the only foundation staff allowed to access this file to facilitate approved implantation. Foundation employees implanted with kill words must complete both (1)trachea surgery to allow for the range of infrasound required to emit kill words, (2)hypno-memetic conditioning causing a fugue state which can be activated by a trigger phrase. The fugue state causes the auditory cortex to briefly limit communication with other brain areas allowing the sound of a kill word to be encoded, but not transmitted into conscious awareness. The trigger phrase, which is known to the Foundation employee, will cause them to enter the fugue state, repeat the kill word, and then return to normal consciousness in a span of several minutes.

Effects: Humans exposed to Kill Words expire immediately from aneurisms. Subjects incapable of hearing are unaffected.

Development: Kill words were adapted by Dr. Langford for Foundation use from █████, initially as a replacement for suicide capsules. Dr. Langford was able to develop a surgical technique to accommodate the auditory range required, with unintentional assistance from SCP-049 following ███████ ████. The development of a means of speaking the kill word without falling victim to it was developed in the subsequent decades after the loss of 128 D-Class and 19 researchers.

Addendum: The safety conditions developed to contain kill words to date have been 92.7% effective in preventing the death of the Foundation agents. While a dramatic improvement over the prior use of kill words as a last resort to escape capture, the high fatality rate limits the number of Foundation employees receiving implantation.


Name: Berryman-Langford Memetic Kill Agent

Class: Termination

Handling and Usage Instructions: This agent may be accessed directly on order of the O5 council. Attempting to access this agent without clearance will result in immediate security response followed by interrogation and termination.

Effects: Immediate death from cardiac arrest. Immediate hallucinations followed by cardiac symptoms leading to cardiac arrest and death within ten to twenty-three minutes of viewing.

Development: Originally developed in 1942 by Doctors Alan Berryman and Charles Langford, remembered in the foundation as 'the fathers of memetics'. Original developments had been stalled for some time, and at this point in the Foundations history no other lethal cognitohazards had yet proved reproducible. Both doctors were known to experiment on themselves while monitoring their vital signs and brain activity with memetic agents thought to be safe. The key breakthrough was made when Dr. Berryman was killed in one such experiment as a result of an unrelated containment breach. The records from his death were used by Dr. Langford to reverse engineer the necessary stimulus to cause instantaneous death, with additional elements used from [REDACTED] and [REDACTED]. Regrettably Dr. Langford was the first individual to be killed by this agent immediately upon its successful creation. It was able to be contained and stored by the founders of MTF Eta-10 ("See No Evil") after an additional 22 foundation staff were also killed upon the memetic agent's discovery.

Addendum: While the Berryman-Langford memetic agent has been successfully used in the highest security areas with a 100% success rate, the swiftness of its effects has noticeably declined. Originally the Berryman-Langford Agent was instantaneously fatal, however the time to death has increased in the past five decades. Currently the average time until expiration is 14 minutes, with the longest duration of life signs following exposure lasting 23 minutes. The cause of these changes is unknown at this time. The time until expiration appears to be unrelated to age, health, physical or psychological characteristics. Autopsy data has been inconclusive. Further testing is ongoing.